A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)

NCT07222189 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

325

Enrollment

INDUSTRY

Sponsor class

Conditions

Colitis Ulcerative
Crohn's Disease

Interventions

DRUG: balinatunfib
DRUG: balinatunfib-matching placebo

Sponsor

Sanofi